BRIEF published on 03/10/2025 at 03:35, 1 year 7 months ago Businesses Show Interest in AI for Sustainability Amid Energy Concerns Cloud Computing Sustainability Goals AI Adoption Energy Concerns Regional Variations
BRIEF published on 03/10/2025 at 03:35, 1 year 7 months ago Les entreprises manifestent leur intérêt pour l'IA au service du développement durable dans un contexte de préoccupations énergétiques Cloud Computing Objectifs De Développement Durable Adoption De L’IA Préoccupations Énergétiques Variations Régionales
BRIEF published on 03/10/2025 at 00:05, 1 year 7 months ago CTT Pharma Joins the OTCQB Market OTCQB Market Expansion Drug Delivery CTT Pharma Dissolvable Strips
BRIEF published on 03/10/2025 at 00:05, 1 year 7 months ago CTT Pharma rejoint le marché OTCQB OTCQB Expansion Du Marché Administration De Médicaments CTT Pharma Bandes Solubles
BRIEF published on 03/09/2025 at 19:18, 1 year 7 months ago EEII AG Announces Board of Directors Reorganization Corporate Governance Leadership Change Swiss Exchange EEII AG Board Reorganization
BRIEF published on 03/09/2025 at 19:18, 1 year 7 months ago EEII AG annonce la réorganisation de son conseil d'administration Gouvernance D'Entreprise Changement De Direction Bourse Suisse EEII AG Réorganisation Du Conseil D'administration
BRIEF published on 03/08/2025 at 19:05, 1 year 7 months ago Sanofi-Aventis Reports Positive Data for Dupixent in Bullous Pemphigoid Clinical Study Dupixent Type 2 Inflammation Bullous Pemphigoid Regulatory Review
BRIEF published on 03/08/2025 at 19:05, 1 year 7 months ago Sanofi-Aventis publie des données positives sur Dupixent dans le traitement de la pemphigoïde bulleuse Étude Clinique Dupixent Pemphigoïde Bulleuse Examen Réglementaire Inflammation De Type 2
BRIEF published on 03/08/2025 at 15:20, 1 year 7 months ago Protagonist Therapeutics Unveils Promising Results for Icotrokinra in Psoriasis Treatment Clinical Trials Protagonist Therapeutics Plaque Psoriasis Icotrokinra Treatment Efficacy
BRIEF published on 03/08/2025 at 15:20, 1 year 7 months ago Protagonist Therapeutics dévoile des résultats prometteurs pour l'icotrokinra dans le traitement du psoriasis Essais Cliniques Thérapeutique Protagoniste Icotrokinra Psoriasis En Plaques Efficacité Du Traitement
Published on 10/21/2026 at 13:30, 12 minutes ago Green Bridge Metals Commences Phase 2 Diamond Drilling Program at the Titac Project, Minnesota, USA
Published on 10/21/2026 at 13:30, 12 minutes ago Adcore Announces Company-Wide Restructuring, Ends Q3 with Higher Cash and Targets Return to Operating Profit in Q4 2026
Published on 10/21/2026 at 13:15, 27 minutes ago Gemdale Gold Completes Phase 2 2026 Drill Program at its Pontio Gold Project, Finland
Published on 10/21/2026 at 13:00, 42 minutes ago Rocky Shore Gold Engages Independent Trading Group as Market Maker
Published on 10/21/2026 at 13:30, 12 minutes ago Nebius brings compute pricing into the open as Europe’s AI builders scale on its cloud
Published on 10/21/2026 at 13:05, 37 minutes ago Rockwell Automation Introduces FactoryTalk Conductor, an AI-Native Orchestration Platform for Industrial Automation
Published on 10/21/2026 at 13:00, 42 minutes ago Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting
Published on 10/21/2026 at 07:00, 6 hours 42 minutes ago Edenred affiche une croissance solide sur les neuf premiers mois de 2026 et confirme ses objectifs pour l’année
Published on 10/21/2026 at 07:00, 6 hours 42 minutes ago Edenred reports sound growth in the first nine months of 2026 and confirms its guidance for the full year
Published on 10/21/2026 at 07:00, 6 hours 42 minutes ago Chiffre d'affaires 3ème trimestre 2026 : 265,5 M€ (+4,8 %)
